Altium Capital Management’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-175,000
| Closed | -$2.77M | – | 46 |
|
|
2024
Q4 | $2.77M | Buy |
175,000
+106,000
| +154% | +$1.68M | 0.79% | 38 |
|
|
2024
Q3 | $4.01M | Buy |
+69,000
| New | +$4.01M | 1.18% | 31 |
|
|
2022
Q4 | – | Sell |
-88,000
| Closed | -$3.31M | – | 111 |
|
|
2022
Q3 | $3.31M | Hold |
88,000
| – | – | 1.21% | 34 |
|
|
2022
Q2 | $2.43M | Sell |
88,000
-38,000
| -30% | -$1.05M | 0.97% | 38 |
|
|
2022
Q1 | $6.85M | Buy |
126,000
+10,000
| +9% | +$544K | 2.29% | 6 |
|
|
2021
Q4 | $6.79M | Sell |
116,000
-10,000
| -8% | -$585K | 1.87% | 10 |
|
|
2021
Q3 | $4.99M | Buy |
+126,000
| New | +$4.99M | 1.31% | 30 |
|